Bicocca Open Archive

Logo unimib boa
CONTER, VALENTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.696
AS - Asia 2.238
EU - Europa 1.938
SA - Sud America 342
Continente sconosciuto - Info sul continente non disponibili 191
AF - Africa 49
OC - Oceania 5
Totale 9.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.470
SG - Singapore 801
IT - Italia 561
CN - Cina 445
VN - Vietnam 331
RU - Federazione Russa 296
BR - Brasile 255
HK - Hong Kong 248
DE - Germania 234
SE - Svezia 215
CA - Canada 174
IE - Irlanda 144
GB - Regno Unito 90
IN - India 84
BD - Bangladesh 82
FR - Francia 81
AT - Austria 53
UA - Ucraina 50
TR - Turchia 47
FI - Finlandia 44
NL - Olanda 33
AR - Argentina 31
ES - Italia 30
ID - Indonesia 29
PL - Polonia 26
IQ - Iraq 25
SA - Arabia Saudita 25
KR - Corea 20
MX - Messico 20
ZA - Sudafrica 20
DK - Danimarca 19
PH - Filippine 15
JP - Giappone 14
PK - Pakistan 14
CO - Colombia 13
EC - Ecuador 13
BE - Belgio 11
GR - Grecia 10
VE - Venezuela 10
PE - Perù 8
CR - Costa Rica 7
CH - Svizzera 6
EU - Europa 6
GT - Guatemala 6
JO - Giordania 6
NP - Nepal 6
RO - Romania 6
TH - Thailandia 6
UZ - Uzbekistan 6
AU - Australia 5
CL - Cile 5
CZ - Repubblica Ceca 5
EG - Egitto 5
IL - Israele 5
MA - Marocco 5
PT - Portogallo 5
AL - Albania 4
JM - Giamaica 4
MY - Malesia 4
NO - Norvegia 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
HN - Honduras 3
KE - Kenya 3
LT - Lituania 3
NI - Nicaragua 3
OM - Oman 3
SN - Senegal 3
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CY - Cipro 2
DZ - Algeria 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
PR - Porto Rico 2
RS - Serbia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BT - Bhutan 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
Totale 9.269
Salva come PNG Salva come JPEG
Città #
Ann Arbor 664
Ashburn 488
Singapore 470
San Jose 288
Hong Kong 242
Fairfield 235
Chandler 211
Wilmington 168
Woodbridge 153
Milan 147
Frankfurt am Main 144
Dublin 143
Houston 142
Toronto 131
New York 119
Seattle 114
Ho Chi Minh City 91
Santa Clara 91
Cambridge 88
Los Angeles 87
Hanoi 86
Dearborn 79
Beijing 70
Council Bluffs 69
Chicago 62
Rome 54
Princeton 53
Vienna 45
Jacksonville 42
Hefei 33
The Dalles 32
Dallas 31
Nanjing 31
Boardman 29
São Paulo 29
Lauterbourg 27
Altamura 26
Lawrence 25
Shanghai 25
Jakarta 24
Buffalo 23
Denver 23
Orem 22
Helsinki 21
Warsaw 21
London 20
Moscow 20
Grafing 19
San Diego 19
Munich 17
Phoenix 17
Guangzhou 16
Paris 16
Chennai 15
Dong Ket 15
Columbus 14
Montreal 13
Naples 13
Turin 13
Da Nang 12
Seoul 12
Tokyo 12
Atlanta 11
Bologna 11
Jeddah 11
Johannesburg 11
Nanchang 11
Poplar 11
Ankara 10
Brooklyn 10
Dhaka 10
Haiphong 10
Mumbai 10
New Delhi 10
Padua 10
Baghdad 9
Figino 9
Salt Lake City 9
Turku 9
Amsterdam 8
Brussels 8
Istanbul 8
Lissone 8
Nuremberg 8
Perugia 8
Rio de Janeiro 8
Stockholm 8
Sulmona 8
Andover 7
Athens 7
Belo Horizonte 7
Brasília 7
Changsha 7
Kunming 7
Las Vegas 7
Ottawa 7
Shenyang 7
Tianjin 7
Verona 7
Hải Dương 6
Totale 5.788
Salva come PNG Salva come JPEG
Nome #
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 477
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 378
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 378
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 359
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 339
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: An international collaborative study 333
Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases 330
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 329
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 326
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 318
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 316
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results 316
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 316
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial 307
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 292
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 287
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 285
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial 276
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols 276
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia 274
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: A retrospective analysis 272
Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study 263
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10–14 years as compared with those aged 15–17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study 248
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) 239
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia 237
A Hematopoietic Stem Cell Transplantation Startup in Iraqi Kurdistan: Results in Thalassemia Patients and Analysis of the Methodology 235
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 232
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease 226
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols 222
Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia 192
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 179
PEDIATRIC PAX5-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IS A HIGH-RISK MOLECULAR SUBGROUP OF B-ALL WITH A POOR MRD-DEPENDENT PROGNOSTIC PROFILE 178
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia 178
Building a Pediatric Hematopoietic Stem Cell Transplantation Unit In Paraguay: Lessons Learned 46
Totale 9.459
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022301 0 0 0 44 21 51 15 20 34 19 40 57
2022/2023831 86 248 48 81 44 128 13 76 50 2 45 10
2023/2024500 26 16 24 59 63 123 103 26 13 6 5 36
2024/20251.378 54 158 97 78 122 42 63 27 167 201 122 247
2025/20263.339 421 127 202 406 428 157 445 136 194 333 250 240
2026/2027722 145 202 329 46 0 0 0 0 0 0 0 0
Totale 9.459